Akums Drugs & Pharma Current Share Price | Akums Drugs & Pharma Stock Screener
AKUMS
Pharmaceuticals
Akums Drugs & Pharma Current Stock Price Today
Live Share Price NSE
₹783.70
▲
17.00 (2.22%)
Live Share Price BSE
₹783.95
▲
17.80 (2.32%)
As of September 18, 2026, the live Akums Drugs & Pharma share price (NSE: AKUMS) is ₹783.70 on NSE and ₹783.95 on BSE, up 2.22% from the previous close, with shares trading between ₹767.10 and ₹790.00 in today's trading session, and a 52-week range of ₹414.05–₹783.70.
Browse AKUMS annual financials to support your investment research.
Use the Akums Drugs & Pharma stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Akums Drugs & Pharma Market Cap
₹12,050.87 Cr.
AKUMS P/E Ratio (TTM)
41.73
Akums Drugs & Pharma P/B Ratio
3.56
EPS (TTM)
₹16.67
Dividend Yield
0.38%
Debt to Equity
0.04
AKUMS 52 Week High
₹783.70
Akums Drugs & Pharma 52 Week Low
₹414.05
Operating Margin
15.00%
Profit Margin
8.44%
AKUMS Revenue (TTM)
₹1,197.00
EBITDA
₹205.00
Net Income
₹101.00
Total Assets
₹5,447.00
Total Equity
₹3,331.00
Akums Drugs & Pharma Current Share Price Chart
Track the current Akums Drugs & Pharma share price and stock price with an interactive chart. Analyse AKUMS price trends, trading volume, historical performance, and volatility across different timeframes — the complete Akums Drugs & Pharma stock quote in one place.
Akums Drugs & Pharma Company Profile - Fundamental Screener
Screen Akums Drugs & Pharma company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for AKUMS shares.
Akums Drugs and Pharmaceuticals Limited is an Indian pharmaceutical contract development and manufacturing organization (CDMO) established in 2004. The company offers a wide range of pharmaceutical products and services both domestically and internationally. Their operations include manufacturing of Active Pharmaceutical Ingredients (APIs), sale of branded pharmaceutical formulations, formulation research and...more
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE09XN01023
Website
https://www.akums.in
Akums Drugs & Pharma Balance Sheet Screener
Screen AKUMS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Total Assets | 5,447 | 4,113 | 3,516 | 3,267 | 3,069 | 2,167 | 2,078 |
| Current Assets | 3,560 | 2,275 | 1,941 | 1,879 | 1,864 | 1,157 | 1,250 |
| Fixed Assets | 1,456 | 1,397 | 1,191 | 1,097 | 1,021 | 904 | 645 |
| Liabilities | |||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 1,021 | 156 | 1,585 | 1,278 | 1,172 | 700 | 627 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||
| Total Equity | 3,331 | 3,064 | 721 | 723 | 625 | 887 | 721 |
| Share Capital | 31 | 31 | 29 | 29 | 14 | 1 | 1 |
| Reserves & Surplus | 3,283 | 3,016 | 681 | 689 | 608 | 884 | 721 |
Akums Drugs & Pharma Income Statement Screener - Profit & Revenue Analysis
Screen Akums Drugs & Pharma income statement and profit fundamentals.
Analyze AKUMS quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Akums Drugs & Pharma share price evaluation.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,197 | 1,193 | 1,194 | 1,050 | 1,051 | 1,081 | 1,030 | 1,050 | 1,026 | 955 | 1,093 | 1,188 | 978 |
| Expenses | 992 | 1,008 | 1,031 | 923 | 895 | 962 | 889 | 912 | 891 | 941 | 989 | 1,057 | 1,095 |
| EBITDA | 205 | 185 | 163 | 127 | 156 | 120 | 141 | 138 | 135 | 14 | 103 | 131 | -117 |
| Operating Profit % | 15.00% | 13.00% | 11.00% | 9.00% | 13.00% | 9.00% | 12.00% | 12.00% | 13.00% | 0.00% | 9.00% | 11.00% | -13.00% |
| Depreciation | 41 | 40 | 40 | 38 | 37 | 40 | 45 | 35 | 34 | 34 | 32 | 30 | 30 |
| Interest | 25 | 24 | 24 | 23 | 23 | 5 | 5 | 12 | 13 | 12 | 12 | 14 | 12 |
| Profit Before Tax | 139 | 121 | 100 | 66 | 96 | 75 | 91 | 92 | 88 | -33 | 59 | 87 | -159 |
| Tax | 38 | 40 | 32 | 23 | 31 | -75 | 25 | 25 | 26 | 7 | -136 | 54 | 29 |
| Net Profit | 101 | 81 | 68 | 43 | 65 | 150 | 66 | 67 | 61 | -40 | 195 | 33 | -187 |
| EPS | 6.53 | 5.53 | 4.33 | 2.66 | 4.15 | 9.64 | 4.26 | 4.37 | 4.21 | -2.89 | 13.21 | 2.22 | -13.16 |
Akums Drugs & Pharma Cash Flow Screener - Liquidity Fundamentals
Screen AKUMS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 1,181 | 465 | 498 | 177 | 32 | 131 | 28 | 89 | 72 |
| Investing Activities | -930 | -548 | -331 | -305 | -235 | -109 | -190 | -123 | -150 |
| Financing Activities | 34 | 73 | -108 | 125 | 236 | -92 | 233 | 37 | 66 |
| Net Cash Flow | 285 | -10 | 59 | -4 | 33 | -70 | 71 | 4 | -11 |
Akums Drugs & Pharma Shareholding Pattern Screener
See Akums Drugs & Pharma shareholding pattern with promoter, FII, and DII holdings.
Check Akums Drugs & Pharma promoter holding and ownership changes for AKUMS on TickJournal.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 75.26% | 75.26% | 75.26% | 75.26% | 75.26% | 75.26% | 75.26% | 75.26% |
| FII Holding | 1.91% | 1.37% | 1.15% | 2.28% | 4.24% | 5.77% | 6.36% | 7.34% |
| DII Holding | 13.44% | 14.35% | 14.40% | 9.28% | 8.85% | 7.40% | 7.00% | 7.52% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 5.57% | 5.34% | 5.51% | 5.01% | 3.60% | 3.41% | 3.33% | 2.11% |
| Other Holding | 3.82% | 3.68% | 3.68% | 8.18% | 8.05% | 8.16% | 8.05% | 7.77% |
| Shareholder Count | 70,289 | 72,589 | 76,869 | 75,365 | 69,424 | 69,366 | 68,410 | 57,531 |
Akums Drugs & Pharma Share Dividend Screener - Share Yield Analysis
Check Akums Drugs & Pharma dividend history with payout and yield data.
View Akums Drugs & Pharma dividend details including ex-dates and amounts for AKUMS stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹3.00 | 0.39% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Akums Drugs & Pharma Stock Index Membership
See which indices include Akums Drugs & Pharma stock.
Check AKUMS index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE INDEX BSE HC
BSE INDEX BSEIPO
BSE INDEX SMLCAP
NIFTY 500
NIFTY IPO
NIFTY MIDSML 400
NIFTY SMLCAP 250
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 MULTICAP
NIFTY500 SHARIAH
Akums Drugs & Pharma Market Events Screener - Corporate Actions
Get Akums Drugs & Pharma corporate actions including splits, bonuses, and buybacks.
Check Akums Drugs & Pharma stock events that may affect AKUMS share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-08 | 2026-08-08 | Quarterly Result Announcement | NA | 4.49% |
| 2026-07-10 | 2026-07-10 | Annual General Meeting | NA | 21.77% |
| 2026-07-03 | 2026-07-03 | Dividend | ₹ 2.00 /share | 17.97% |
| 2026-07-03 | 2026-07-03 | Dividend | ₹ 1.00 /share | 17.97% |
| 2026-05-14 | 2026-05-14 | Quarterly Result Announcement | NA | -3.02% |
| 2026-02-13 | 2026-02-13 | Quarterly Result Announcement | NA | 5.56% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -0.29% |
| 2025-08-08 | 2025-08-08 | Quarterly Result Announcement | NA | -4.50% |
| 2025-07-18 | 2025-07-18 | Annual General Meeting | NA | -1.09% |
| 2025-05-26 | 2025-05-26 | Quarterly Result Announcement | NA | 3.58% |
| 2025-02-06 | 2025-02-06 | Quarterly Result Announcement | NA | 0.66% |
| 2024-11-09 | 2024-11-09 | Quarterly Result Announcement | NA | -5.76% |
Akums Drugs & Pharma Competitors Screener - Peer Comparison
Screen AKUMS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 440,278 | 36.48 | 61,674 | 12.69% | 11,565 | 33.19 |
| Divis Laboratories | 244,178 | 84.64 | 11,067 | 13.95% | 2,568 | 59.21 |
| Torrent Pharmaceuticals | 184,478 | 87.77 | 13,886 | 20.34% | 2,138 | 44.26 |
| Zydus Life Science | 110,585 | 24.32 | 27,658 | 17.64% | 5,026 | 41.59 |
| Cipla | 109,140 | 32.86 | 29,045 | 2.24% | 3,870 | 32.08 |
| Laurus Labs | 104,025 | 97.64 | 6,868 | 22.01% | 890 | 60.27 |
| Dr Reddys Laboratories | 95,570 | 30.44 | 35,059 | 3.90% | 4,158 | 41.23 |
| Aurobindo Pharma | 95,513 | 25.98 | 34,145 | 5.56% | 3,503 | 53.00 |
| Lupin | 94,336 | 17.27 | 29,039 | 26.75% | 5,356 | 24.64 |
| Mankind Pharma | 94,184 | 45.49 | 14,636 | 14.85% | 1,938 | 37.66 |
Akums Drugs & Pharma Company Announcements - News Screener
Screen AKUMS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-03 | ESG Rating | - |
| 2026-08-25 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-24 | Update On Schedule Of The Investors/Analysts Meet To Be Held On August 25 2026 | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-08-10 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-10 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-08-10 | Newspaper Publication | - |
| 2026-08-10 | Monitoring Agency Report | - |
| 2026-08-08 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-08-08 | Press Release | - |
| 2026-08-08 | Un-Audited Financial Results For The Quarter Ended 30Th June 2026 | - |
| 2026-08-08 | Board Meeting Outcome for Un-Audited Financial Results For The Quarter Ended 30Th June 2026 | - |
| 2026-08-05 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-05 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-05 | Board Meeting Intimation for Un-Audited (Standalone & Consolidated) Financial Results For The Quarter Ended On 30Th June 2026 | - |
| 2026-07-23 | Announcement under Regulation 30 (LODR)-Acquisition | - |
| 2026-07-11 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-07-10 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-07-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |